https://socictopen.socict.org/files/original/96c0bc572ec92604fd4c3035daa6eafd.pdf 39da239a98f475a534dfaa5cbdc7a44d Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource How Close are We to a COVID-19 Vaccine? Creator An entity primarily responsible for making the resource Kayhan Ozkan Description An account of the resource This review provides an overview regarding the main aspects of candidate COVID-19 vaccines andpathophysiology of disease. The types of biotechnological candidate vaccines to be developedagainst COVID-19, their degree of protection and the pathophysiological mechanism of the diseasewere analyzed in this review article. The literature data on which cruxes for the development ofbiotechnological candidate vaccines to be wended are based was researched. Data that could givereference to various biotechnological candidate vaccines were reviewed. For this purpose, up-todate literature data was utilized. The ways to succeed in the development of a vaccine requiring atechnological infrastructure are to synthesize the data obtained from long term trials and to put theminto practice subsequently. The vaccines to be developed by means of recombinant DNA technology willbe a source of inspiration to people for further studies. After a rapid process of vaccine development,the use of COVID-19 vaccine can be mainstreamed among people to prevent the disease. As a resultof these practices, the evaluation of which vaccine will be more safe, reliable and effective will beperformed after phase studies. Date A point or period of time associated with an event in the lifecycle of the resource 2020 Subject The topic of the resource immune response, Recombinant, COVID-19 vaccine, atteneu virus, phase studies Identifier An unambiguous reference to the resource within a given context DOI: 10.22207/JPAM.14.SPL1.26 Source A related resource from which the described resource is derived Journal of Pure and Applied Microbiology Publisher An entity responsible for making the resource available Journal of Pure and Applied Microbiology Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Microbiology